This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
LIAISON C-Peptid
- Starting date:
- February 28, 2017
- Posting date:
- March 24, 2017
- Type of communication:
- Medical Device Recall
- Subcategory:
- Medical Device
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Medical Devices
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-62796
Reason
Recent internal testing highlighted the cross reactivity of LIAISON C-Peptid assay with human proinsulin which, in some rare cases, may result in an apparent increased c-peptide concentration in affected sample(s) tested using the LIAISON C-Peptid assay.
Affected products
LIAISON C-Peptid
Lot or serial number
All lots
Model or catalog number
316171
Companies
- Manufacturer
-
Diasorin Inc.
1951 Northwestern Avenue, P.O. Box 285
Stillwater
55082
Minnesota
UNITED STATES